99 related articles for article (PubMed ID: 3841831)
1. Role of thymidylate synthetase in the cytostatic activity of pyrimidine nucleoside analogues.
Balzarini J
Bull Mem Acad R Med Belg; 1985; 140(11):432-40. PubMed ID: 3841831
[No Abstract] [Full Text] [Related]
2. Incorporation of 5-substituted pyrimidine nucleoside analogues into DNA of a thymidylate synthetase-deficient murine FM3A carcinoma cell line.
Balzarini J; De Clercq E; Ayusawa D; Seno T
Methods Find Exp Clin Pharmacol; 1985 Jan; 7(1):19-28. PubMed ID: 3990443
[TBL] [Abstract][Full Text] [Related]
3. Thymidylate synthetase as target enzyme for the inhibitory activity of 5-substituted 2'-deoxyuridines on mouse leukemia L1210 cell growth.
De Clercq E; Balzarini J; Torrence PF; Mertes MP; Schmidt CL; Shugar D; Barr PJ; Jones AS; Verhelst G; Walker RT
Mol Pharmacol; 1981 Mar; 19(2):321-30. PubMed ID: 7231392
[No Abstract] [Full Text] [Related]
4. Cytotoxicity of 5-fluoro-5'-O-nitro-2'-deoxyuridine, a new fluorinated pyrimidine derivative, in L1210 cultures.
Roberts D; Franklin P; Odom G; Peck C; Chwang TL
Mol Pharmacol; 1982 Nov; 22(3):760-5. PubMed ID: 6218391
[TBL] [Abstract][Full Text] [Related]
5. Role of thymidine kinase and thymidylate synthetase in the cytostatic, antimetabolic, and antitumor effects of the carbocyclic analogue of 5-nitro-2'-deoxyuridine. A comparison with 5-nitro-2'-deoxyuridine.
Balzarini J; De Clercq E; Herdewijn P; Robins MJ
Mol Pharmacol; 1985 May; 27(5):578-83. PubMed ID: 3990680
[TBL] [Abstract][Full Text] [Related]
6. Effect of the dialdehyde derivative of 5'-deoxyinosine on pyrimidine deoxyribonucleoside metabolism in L1210 cells.
Ohmstede CA; Cory JG
Biochem Pharmacol; 1985 May; 34(10):1717-24. PubMed ID: 3839126
[TBL] [Abstract][Full Text] [Related]
7. Role of deoxycytidine kinase in the inhibitory activity of 5-substituted 2'-deoxycytidines and cytosine arabinosides on tumor cell growth.
Balzarini J; De Clercq E
Mol Pharmacol; 1983 Jan; 23(1):175-81. PubMed ID: 6306422
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antineoplastic activity of 3'-azido and 3'-amino analogues of pyrimidine deoxyribonucleoside.
Lin TS; Mancini WR
J Med Chem; 1983 Apr; 26(4):544-8. PubMed ID: 6834387
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of thymidylate synthase in intact L1210 cells by ara-C, daunomycin, hydroxyurea and 3,4-dihydroxybenzylamine.
FitzGerald GB; Ratliff J; Wick MM
Anticancer Drug Des; 1987 Apr; 1(4):281-9. PubMed ID: 2967076
[TBL] [Abstract][Full Text] [Related]
10. Pyrimidines and their nucleosides.
Renis HE
Antibiot Chemother (1971); 1980; 27():164-207. PubMed ID: 6773471
[No Abstract] [Full Text] [Related]
11. Levels of thymidylate synthetase during normal culture growth of L1210 cells.
Cadman E; Heimer R
Cancer Res; 1986 Mar; 46(3):1195-8. PubMed ID: 3943093
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of uridine kinase and the salvage of uridine by modified pyrimidine nucleosides.
Moyer JD; Karle JM; Malinowski N; Marquez VE; Salam MA; Malspeis L; Cysyk RL
Mol Pharmacol; 1985 Nov; 28(5):454-60. PubMed ID: 2997596
[TBL] [Abstract][Full Text] [Related]
13. Antiviral, antitumor, and thymidylate synthetase inhibition studies of 5-substituted styryl derivatives of 2'-deoxyuridine and their 5'-phosphates.
De Clercq E; Balzarini J; Descamps J; Bigge CF; Chang CT; Kalaritis P; Mertes MP
Biochem Pharmacol; 1981 Mar; 30(5):495-502. PubMed ID: 6261769
[No Abstract] [Full Text] [Related]
14. The cytostatic activity of pyrimidine nucleosides is strongly modulated by Mycoplasma hyorhinis infection: Implications for cancer therapy.
Bronckaers A; Balzarini J; Liekens S
Biochem Pharmacol; 2008 Jul; 76(2):188-97. PubMed ID: 18555978
[TBL] [Abstract][Full Text] [Related]
15. Pyrimidine nucleosides. 6. Syntheses and anticancer activities of N4-substituted 2,2'-anhydronucleosides.
Kanai T; Ichino M
J Med Chem; 1974 Oct; 17(10):1076-8. PubMed ID: 4529302
[No Abstract] [Full Text] [Related]
16. Inhibition of microorganisms by pyrimidine nucleosides.
Mehta BM; Hutchison DJ
Ann N Y Acad Sci; 1975 Aug; 255():559-63. PubMed ID: 811152
[No Abstract] [Full Text] [Related]
17. Potentiation of the cytotoxicity of thymidylate synthase (TS) inhibitors by dipyridamole analogues with reduced alpha1-acid glycoprotein binding.
Curtin NJ; Bowman KJ; Turner RN; Huang B; Loughlin PJ; Calvert AH; Golding BT; Griffin RJ; Newell DR
Br J Cancer; 1999 Aug; 80(11):1738-46. PubMed ID: 10468290
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of 3'- and 5'-nitrooxy pyrimidine nucleoside nitrate esters: "nitric oxide donor" agents for evaluation as anticancer and antiviral agents.
Naimi E; Zhou A; Khalili P; Wiebe LI; Balzarini J; De Clercq E; Knaus EE
J Med Chem; 2003 Mar; 46(6):995-1004. PubMed ID: 12620076
[TBL] [Abstract][Full Text] [Related]
19. Thymidylate synthetase-positive and -negative murine mammary FM3A carcinoma cells as a useful system for detecting thymidylate synthetase inhibitors.
Balzarini J; de Clercq E; Ayusawa D; Seno T
FEBS Lett; 1984 Jul; 173(1):227-32. PubMed ID: 6745430
[TBL] [Abstract][Full Text] [Related]
20. Interaction of thymidylate synthetase and dihydrofolate reductase enzymes in vitro and in vivo.
Kawai M; Hillcoat BL
Cancer Res; 1974 Jul; 34(7):1619-26. PubMed ID: 4833915
[No Abstract] [Full Text] [Related]
[Next] [New Search]
